RESEARCH-USE BIOSIMILAR ANTIBODY
Ociperlimab
Monoclonal antibody · IgG1
Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer.
TARGETTIGIT
YMonoclonal antibody
CATALOGSC-BS-321
CATALOG NUMBERSC-BS-321
MOLECULAR WEIGHTApprox. 145.12 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Ociperlimab is a humanized IgG1 anti-TIGIT antibody. Ociperlimab binds to the extracellular domain of human TIGIT with high affinity (KD = 0.135 nM). Ociperlimab blocks the interaction between TIGIT and its ligands PVR or PVR-L2. Ociperlimab can be used in research of cancer.
Ociperlimab is a recombinant research-use antibody directed against TIGIT.